Description
This report provides an overview of the Newborn Metabolic Screening (NMS) Program in Alberta from 2002 to 2005. A brief history and an overview of the roles of stakeholders in the current operation of the program are provided. Data from the NMS application are used to report on key program indicators. During this period, the Alberta NMS program screened for three conditions: phenylketonuria, congenital hypothyroidism and biotinidase deficiency. Results from this analysis indicate that the program is functioning effectively. Greater than 99 per cent of infants born in Alberta receive an initial screen. More than 98 per cent of infants have the initial screen collected in the target period. Approximately one out of every 2,200 infants (74 in total) have screened positive for one of the three conditions since January 1, 2002.
Updated
November 1, 2006
Tags
Resources
Title and publication information
Type
Extent
28 pages
Frequency
Once
Publisher / Creator Information
Resource Dates
Date Created
2006-11-01
Date Added
2017-05-19T16:40:11.803971
Date Modified
2006-11-01
Date Issued
2006-11-01
Audience information
Language
Identifiers
ISBN (pdf)
0778535010
ISBN (print)
0778535002